Adverum Biotechnologies Reports Second Quarter 2019 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. MSFT

Go back to Adverum Biotechnologies Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Adverum Biotechnologies (ADVM) Tops Q2 EPS by 6c

August 8, 2019 4:40 PM EDT

Adverum Biotechnologies (NASDAQ: ADVM) reported Q2 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $0 versus the consensus estimate of $300 thousand.

We are extremely pleased with the clinical and regulatory progress made with our lead clinical candidate,... More